Edition:
India

People: Atara Biotherapeutics Inc (ATRA.OQ)

ATRA.OQ on NASDAQ Stock Exchange Global Select Market

23.21USD
24 May 2019
Change (% chg)

$-0.28 (-1.19%)
Prev Close
$23.49
Open
$23.66
Day's High
$24.32
Day's Low
$22.77
Volume
120,012
Avg. Vol
146,211
52-wk High
$52.65
52-wk Low
$22.36

Newell, Joseph 

Mr. Joseph Newell serves as Executive Vice President and Chief Technical Operations Officer of the Company. He served as our Executive Vice President and Chief Technical Operations Officer since April 2017. From July 2015 to April 2017, he was Vice President, North America Manufacturing at Alexion Pharmaceuticals, Inc. a publicly traded biotechnology company. From March 2008 to July 2015, he served various roles within Amgen, Inc., a publicly traded human therapeutics company, including as Executive Director and Plant Manager from August 2012 to September 2014 and Executive Director, Operations Strategic Planning from September 2014 to June 2015. He received a B.S. from California State Polytechnic University – Pomona.

Basic Compensation

Total Annual Compensation, USD 450,696
Restricted Stock Award, USD 153,000
Long-Term Incentive Plans, USD --
All Other, USD 1,038,120
Fiscal Year Total, USD 1,641,820

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Isaac Ciechanover

3,366,820

Utpal Koppikar

--

Joseph Newell

1,641,820

Christopher Haqq

3,298,020

Mitchall Clark

1,402,910

Gad Soffer

3,098,040
As Of  31 Dec 2017